{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:01:56Z","timestamp":1792425716568,"version":"4.5.0"},"reference-count":79,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2022.5964","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T15:41:16Z","timestamp":1650901276000},"page":"e225964","source":"Crossref","is-referenced-by-count":16,"title":["Pediatric Outpatient Prescriptions in Countries With Advanced Economies in the 21st Century"],"prefix":"10.1001","volume":"5","author":[{"given":"Marion","family":"Taine","sequence":"first","affiliation":[{"name":"EPI-PHARE Scientific Interest Group in Epidemiology of Health Products, French National Agency for the Safety of Medecines and Health Products, French National Health Insurance, Saint Denis, France"},{"name":"Obstetrical, Perinatal and Pediatric Epidemiology Research Team, Centre of Research in Epidemiology and Statistics, Universit\u00e9 de Paris, National Institute of Health and Medical Research, F-75004, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucile","family":"Offredo","sequence":"additional","affiliation":[{"name":"EPI-PHARE Scientific Interest Group in Epidemiology of Health Products, French National Agency for the Safety of Medecines and Health Products, French National Health Insurance, Saint Denis, France"},{"name":"Obstetrical, Perinatal and Pediatric Epidemiology Research Team, Centre of Research in Epidemiology and Statistics, Universit\u00e9 de Paris, National Institute of Health and Medical Research, F-75004, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Weill","sequence":"additional","affiliation":[{"name":"EPI-PHARE Scientific Interest Group in Epidemiology of Health Products, French National Agency for the Safety of Medecines and Health Products, French National Health Insurance, Saint Denis, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary","family":"Dray-Spira","sequence":"additional","affiliation":[{"name":"EPI-PHARE Scientific Interest Group in Epidemiology of Health Products, French National Agency for the Safety of Medecines and Health Products, French National Health Insurance, Saint Denis, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Zureik","sequence":"additional","affiliation":[{"name":"EPI-PHARE Scientific Interest Group in Epidemiology of Health Products, French National Agency for the Safety of Medecines and Health Products, French National Health Insurance, Saint Denis, France"},{"name":"Versailles Saint-Quentin-en-Yvelines University, Versailles, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Chalumeau","sequence":"additional","affiliation":[{"name":"Obstetrical, Perinatal and Pediatric Epidemiology Research Team, Centre of Research in Epidemiology and Statistics, Universit\u00e9 de Paris, National Institute of Health and Medical Research, F-75004, Paris, France"},{"name":"Department of General Pediatrics and Pediatric Infectious Diseases, Necker-Enfants Malades Hospital, Assistance Publique-H\u00f4pitaux de Paris, Universit\u00e9 de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,4,25]]},"reference":[{"issue":"3","key":"zoi220187r3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ijantimicag.2012.09.003","article-title":"Understanding physician antibiotic prescribing behaviour: a systematic review of qualitative studies.","volume":"41","author":"Teixeira Rodrigues","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"zoi220187r4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1471-2296-15-34","article-title":"Irrational prescribing of over-the-counter (OTC) medicines in general practice: testing the feasibility of an educational intervention among physicians in five European countries.","volume":"15","author":"Lionis","year":"2014","journal-title":"BMC Fam Pract"},{"issue":"3","key":"zoi220187r5","first-page":"175","article-title":"Has the \u2018therapeutic orphan\u2019 finally been adopted?","volume":"8","author":"Christensen","year":"2003","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"7556","key":"zoi220187r6","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1136\/bmj.332.7556.1464","article-title":"Rational prescribing for children.","volume":"332","author":"Sutcliffe","year":"2006","journal-title":"BMJ"},{"issue":"6","key":"zoi220187r7","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1056\/NEJM199002083220604","article-title":"Phenobarbital for febrile seizures\u2014effects on intelligence and on seizure recurrence.","volume":"322","author":"Farwell","year":"1990","journal-title":"N Engl J Med"},{"issue":"19","key":"zoi220187r8","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1001\/jama.1977.03270460055020","article-title":"Prescribing of tetracycline to children less than 8 years old: a two-year epidemiologic study among ambulatory Tennessee Medicaid recipients.","volume":"237","author":"Ray","year":"1977","journal-title":"JAMA"},{"issue":"4","key":"zoi220187r9","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/MPG.0000000000000657","article-title":"Prokinetics prescribing in paediatrics: evidence on cisapride, domperidone, and metoclopramide.","volume":"60","author":"Mt-Isa","year":"2015","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"11","key":"zoi220187r10","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.cppeds.2018.09.002","article-title":"The burden and impact of antibiotic prescribing in ambulatory pediatrics.","volume":"48","author":"Yonts","year":"2018","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"issue":"426","key":"zoi220187r11","first-page":"880","article-title":"Everyday symptoms in childhood: occurrence and general practitioner consultation rates.","volume":"48","author":"Bruijnzeels","year":"1998","journal-title":"Br J Gen Pract"},{"issue":"4","key":"zoi220187r12","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/fampra\/cmi035","article-title":"The prevalence of symptoms and consultations in pre-school children in the Avon Longitudinal Study of Parents and Children (ALSPAC): a prospective cohort study.","volume":"22","author":"Hay","year":"2005","journal-title":"Fam Pract"},{"issue":"1","key":"zoi220187r13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/jcpt.2018.43.issue-1","article-title":"Patients\u2019 intention to consume prescribed and non-prescribed medicines: a study based on the theory of planned behaviour in selected European countries.","volume":"43","author":"Kamekis","year":"2018","journal-title":"J Clin Pharm Ther"},{"issue":"9","key":"zoi220187r14","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.healthpol.2015.06.006","article-title":"General practitioners\u2019 intention to prescribe and prescribing patterns in selected European settings: the OTCSOCIOMED project.","volume":"119","author":"Tsiantou","year":"2015","journal-title":"Health Policy"},{"issue":"1","key":"zoi220187r15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.healthpol.2006.11.005","article-title":"Conditional reimbursement within the Dutch drug policy.","volume":"84","author":"Niezen","year":"2007","journal-title":"Health Policy"},{"issue":"10100","key":"zoi220187r16","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.","volume":"390","author":"GBD 2016 Disease and Injury Incidence and Prevalence Collaborators","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"zoi220187r18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00228-004-0739-y","article-title":"Drug utilisation in outpatient children: a comparison among Tenerife, Valencia, and Barcelona (Spain), Toulouse (France), Sofia (Bulgaria), Bratislava (Slovakia) and Smolensk (Russia).","volume":"60","author":"Sanz","year":"2004","journal-title":"Eur J Clin Pharmacol"},{"key":"zoi220187r19","doi-asserted-by":"publisher","first-page":"a2245","DOI":"10.1136\/bmj.a2245","article-title":"Drug use in children: cohort study in three European countries.","volume":"337","author":"Sturkenboom","year":"2008","journal-title":"BMJ"},{"issue":"5","key":"zoi220187r20","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s40272-018-0303-3","article-title":"Trends in outpatient prescription medicine use in New Zealand children 2010-2015: a national population-based study.","volume":"20","author":"Tomlin","year":"2018","journal-title":"Paediatr Drugs"},{"issue":"19","key":"zoi220187r21","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1001\/jama.2018.5690","article-title":"Trends in prescription medication use among children and adolescents\u2014United States, 1999-2014.","volume":"319","author":"Hales","year":"2018","journal-title":"JAMA"},{"key":"zoi220187r22","article-title":"Paediatric outpatient prescriptions in France between 2010 and 2019: a nationwide population-based study: paediatric outpatient prescriptions in France, 2010 to 2019.","volume":"7","author":"Taine","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"zoi220187r23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jpeds.2019.09.017","article-title":"Association between national treatment guidelines for upper respiratory tract infections and outpatient pediatric antibiotic use in France: an interrupted time-series analysis.","volume":"216","author":"Trinh","year":"2020","journal-title":"J Pediatr"},{"issue":"8","key":"zoi220187r24","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00228-009-0679-7","article-title":"Drug prescriptions to outpatient children: a review of the literature.","volume":"65","author":"Clavenna","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"zoi220187r25","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/(ISSN)1099-1751","article-title":"An overview of pharmaceutical policy in four countries: France, Germany, the Netherlands and the United Kingdom.","volume":"20","author":"Mossialos","year":"2005","journal-title":"Int J Health Plann Manage"},{"key":"zoi220187r26","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-analyses: the PRISMA statement.","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"issue":"4","key":"zoi220187r30","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1177\/1355819615593302","article-title":"Why does increasing public access to medicines differ between countries: qualitative comparison of nine countries.","volume":"20","author":"Gauld","year":"2015","journal-title":"J Health Serv Res Policy"},{"issue":"1","key":"zoi220187r31","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1186\/s12889-017-4923-2","article-title":"Prices of over-the-counter drugs used by 15-year-old adolescents in Germany and their association with socioeconomic background.","volume":"17","author":"Italia","year":"2017","journal-title":"BMC Public Health"},{"issue":"9","key":"zoi220187r32","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jclinepi.2011.11.014","article-title":"Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement.","volume":"65","author":"Hoy","year":"2012","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"zoi220187r33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.15171\/ijhpm.2014.71","article-title":"The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence.","volume":"3","author":"Munn","year":"2014","journal-title":"Int J Health Policy Manag"},{"issue":"7","key":"zoi220187r34","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.mayocp.2013.04.021","article-title":"Age and sex patterns of drug prescribing in a defined American population.","volume":"88","author":"Zhong","year":"2013","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"zoi220187r35","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-2623","article-title":"Global burden of childhood epilepsy, intellectual disability, and sensory impairments.","volume":"146","author":"Olusanya","year":"2020","journal-title":"Pediatrics"},{"issue":"5","key":"zoi220187r36","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-3908","article-title":"Incidence and prevalence of childhood epilepsy: a nationwide cohort study.","volume":"139","author":"Aaberg","year":"2017","journal-title":"Pediatrics"},{"issue":"3","key":"zoi220187r37","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/bcp.2008.65.issue-3","article-title":"Identifying how age and gender influence prescription drug use in a primary health care environment in Catalonia, Spain.","volume":"65","author":"Fern\u00e1ndez-Liz","year":"2008","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"zoi220187r38","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00228-012-1343-1","article-title":"Prescription drug dispensing profiles for one million children: a population-based analysis.","volume":"69","author":"Zhang","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"issue":"4 Pt 1","key":"zoi220187r45","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1542\/peds.103.4.711","article-title":"The relationship between perceived parental expectations and pediatrician antimicrobial prescribing behavior.","volume":"103","author":"Mangione-Smith","year":"1999","journal-title":"Pediatrics"},{"issue":"6","key":"zoi220187r46","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1093\/jac\/dkx060","article-title":"Antibiotic consumption by New Zealand children: exposure is near universal by the age of 5?years.","volume":"72","author":"Hobbs","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"zoi220187r47","doi-asserted-by":"crossref","DOI":"10.1136\/archdischild-2016-311535.57","article-title":"Long-course oral corticosteroid toxicity in children.","volume":"101","author":"Aljebab","year":"2016","journal-title":"Arch Dis Child"},{"key":"zoi220187r48","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2147\/JAA","article-title":"Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study.","volume":"11","author":"Price","year":"2018","journal-title":"J Asthma Allergy"},{"issue":"7","key":"zoi220187r49","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-015905","article-title":"Prevalence and prescription patterns of oral glucocorticoids in adults: a retrospective cross-sectional and cohort analysis in France.","volume":"7","author":"B\u00e9nard-Laribi\u00e8re","year":"2017","journal-title":"BMJ Open"},{"issue":"3","key":"zoi220187r50","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1530\/EJE-19-0305","article-title":"Fifteen-year nationwide trends in systemic glucocorticoid drug use in Denmark.","volume":"181","author":"Laugesen","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"zoi220187r51","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/cen.v92.1","article-title":"High prescription rate of oral glucocorticoids in children and adults: a retrospective cohort study from western Sweden.","volume":"92","author":"Einarsdottir","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"zoi220187r52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165657","article-title":"Incidence and determinants of ventilation tubes in Denmark.","volume":"11","author":"Pedersen","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"zoi220187r53","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1177\/0194599815623467","article-title":"Clinical practice guideline: otitis media with effusion (update).","volume":"154","author":"Rosenfeld","year":"2016","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"8","key":"zoi220187r56","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/pai.12372","article-title":"Decline in admissions for childhood asthma, a 26-year period population-based study.","volume":"26","author":"Mikalsen","year":"2015","journal-title":"Pediatr Allergy Immunol"},{"issue":"7","key":"zoi220187r57","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.arcped.2013.04.017","article-title":"Les hospitalisations pour asthme chez l'enfant en France, 2002-2010. Admissions for pediatric asthma in France, 2002-2010.","volume":"20","author":"Delmas","year":"2013","journal-title":"Arch Pediatr"},{"issue":"6","key":"zoi220187r58","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1002\/ppul.v56.6","article-title":"Regional differences in pediatric asthma hospital admissions: national data from Israel 1996-2017.","volume":"56","author":"Reiter","year":"2021","journal-title":"Pediatr Pulmonol"},{"issue":"155","key":"zoi220187r59","volume":"29","author":"Price","year":"2020"},{"issue":"5","key":"zoi220187r60","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-4146","article-title":"Oral corticosteroid prescribing for children with asthma in a Medicaid managed care program.","volume":"139","author":"Farber","year":"2017","journal-title":"Pediatrics"},{"issue":"3","key":"zoi220187r61","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1164\/rccm.201904-0903SO","article-title":"Systematic literature review of systemic corticosteroid use for asthma management.","volume":"201","author":"Bleecker","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"155","key":"zoi220187r62","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0085-2019","article-title":"How can we minimise the use of regular oral corticosteroids in asthma?","volume":"29","author":"Bourdin","year":"2020","journal-title":"Eur Respir Rev"},{"issue":"8","key":"zoi220187r63","first-page":"2344","article-title":"Community antibiotic prescribing for children in France from 2015 to 2017: a cross-sectional national study.","volume":"75","author":"Trinh","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"zoi220187r64","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/jac\/dkx502","article-title":"Actual versus \u2018ideal\u2019 antibiotic prescribing for common conditions in English primary care.","volume":"73","author":"Pouwels","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"17","key":"zoi220187r65","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1001\/jama.2016.4151","article-title":"Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010-2011.","volume":"315","author":"Fleming-Dutra","year":"2016","journal-title":"JAMA"},{"issue":"1","key":"zoi220187r66","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S1473-3099(18)30605-4","article-title":"Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis.","volume":"19","author":"Cassini","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"zoi220187r67","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S2215-0366(20)30137-1","article-title":"Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis.","volume":"7","author":"Zhou","year":"2020","journal-title":"Lancet Psychiatry"},{"issue":"10","key":"zoi220187r68","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/S2215-0366(18)30293-1","article-title":"Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases.","volume":"5","author":"Raman","year":"2018","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"zoi220187r69","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/acps.v141.1","article-title":"Trends in antidepressant use among children and adolescents: a Scandinavian drug utilization study.","volume":"141","author":"Wesselhoeft","year":"2020","journal-title":"Acta Psychiatr Scand"},{"issue":"10","key":"zoi220187r70","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s00228-019-02711-3","article-title":"Prescription prevalence of psychotropic drugs in children and adolescents: an analysis of international data.","volume":"75","author":"Piovani","year":"2019","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"zoi220187r71","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/wps.v19.2","article-title":"Safety of 80 antidepressants, antipsychotics, anti-attention-deficit\/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects.","volume":"19","author":"Solmi","year":"2020","journal-title":"World Psychiatry"},{"issue":"1","key":"zoi220187r72","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1192\/bji.2017.3","article-title":"The place of psychoanalysis in French psychiatry.","volume":"15","author":"Botbol","year":"2018","journal-title":"BJPsych Int"},{"issue":"4","key":"zoi220187r73","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1080\/13625180802511541","article-title":"Women\u2019s contraceptive practices and sexual behaviour in Europe.","volume":"13","author":"Cibula","year":"2008","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"10","key":"zoi220187r74","first-page":"A4936","article-title":"Adolescent girls in Denmark use oral contraceptives at an increasingly young age, and with more pauses and shifts.","volume":"61","author":"L\u00f8kkegaard","year":"2014","journal-title":"Dan Med J"},{"issue":"1","key":"zoi220187r75","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/aogs.2017.96.issue-1","article-title":"Contraceptive use in the Nordic countries.","volume":"96","author":"Lindh","year":"2017","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"3","key":"zoi220187r76","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00150-2016","article-title":"Variations in the prevalence of childhood asthma and wheeze in MeDALL cohorts in Europe.","volume":"3","author":"Uphoff","year":"2017","journal-title":"ERJ Open Res"},{"issue":"7","key":"zoi220187r77","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/(ISSN)1099-1557","article-title":"Drug utilization statistics for individual-level pharmacy dispensing data.","volume":"14","author":"Hallas","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"10","key":"zoi220187r78","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1007\/s00431-018-3196-9","article-title":"A survey of medicine use in children and adolescents in Austria.","volume":"177","author":"Rauch","year":"2018","journal-title":"Eur J Pediatr"},{"issue":"1","key":"zoi220187r79","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-032426","article-title":"Application of a common data model (CDM) to rank the paediatric user and prescription prevalence of 15 different drug classes in South Korea, Hong Kong, Taiwan, Japan and Australia: an observational, descriptive study.","volume":"10","author":"Brauer","year":"2020","journal-title":"BMJ Open"},{"key":"zoi220187r28","volume-title":"Pharmaceutical Prices in the 21st Century","author":"H\u00e5konsen","year":"2015"},{"key":"zoi220187r1","unstructured":"World Health Organization. Promoting rational use of medicines. Accessed February 14, 2021. https:\/\/www.who.int\/activities\/promoting-rational-use-of-medicines\/"},{"key":"zoi220187r2","unstructured":"Organisation for Economic Co-operation and Development. Member countries. Accessed July 1, 2020. https:\/\/www.oecd.org\/about\/members-and-partners\/"},{"key":"zoi220187r17","unstructured":"World Health Organization. Introduction to drug utilization research. Accessed July 1, 2020. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/42627\/924156234X.pdf?sequence=1&isAllowed=y"},{"key":"zoi220187r27","unstructured":"Centre for Reviews and Dissemination. Systematic reviews: CRD\u2019s guidance for undertaking reviews in health care. Accessed January 1, 2021. https:\/\/www.york.ac.uk\/media\/crd\/Systematic_Reviews.pdf"},{"key":"zoi220187r29","unstructured":"Danish Medicines Agency. Reimbursement and prices. Accessed May 8, 2021. https:\/\/laegemiddelstyrelsen.dk\/en\/reimbursement\/"},{"key":"zoi220187r39","unstructured":"Osservatorio Nazionale sull\u2019impiego dei Medicinal. L\u2019uso dei farmaci in gravidanza: rapporto nazionale. Accessed January 1, 2021. https:\/\/www.aifa.gov.it\/documents\/20142\/1228539\/Osmed_uso_farmaci_in_gravidanza.pdf"},{"key":"zoi220187r40","unstructured":"Sundhedsdata-Styrelsen. Medstat.dk. Accessed January 1, 2021. https:\/\/medstat.dk\/en"},{"key":"zoi220187r41","unstructured":"Healthcare Institute Netherlands. De GIPdatabank. Accessed March 1, 2022. https:\/\/www.gipdatabank.nl\/"},{"key":"zoi220187r42","unstructured":"Norwegian Institute of Public Health. Norwegian prescription database. Updated April 2021. Accessed July 1, 2020. http:\/\/www.norpd.no"},{"key":"zoi220187r43","unstructured":"Socialstyrelsen. Statistikdatabas f\u00f6r l\u00e4kemedel. Accessed January 1, 2021. https:\/\/sdb.socialstyrelsen.se\/if_lak\/val.aspx"},{"key":"zoi220187r44","unstructured":"The Commonwealth Fund. Country profiles: international health care system profiles. Accessed January 1, 2021. https:\/\/www.commonwealthfund.org\/international-health-policy-center\/countries"},{"key":"zoi220187r54","unstructured":"Soci\u00e9t\u00e9 Fran\u00e7aise d\u2019ORL et de Chirurgie Cervico-Faciale. Prise en charge th\u00e9rapeutique des otites s\u00e9romuqueuses de l\u2019enfant. Accessed March 1, 2022. https:\/\/www.orlfrance.org\/lorem-ipsum-dolor-sit-amet\/"},{"key":"zoi220187r55","unstructured":"The Global Initiative for Asthma. Pocket guide for asthma management and prevention. Accessed February 1, 2021. https:\/\/ginasthma.org\/pocket-guide-for-asthma-management-and-prevention"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2791284\/taine_2022_oi_220187_1649858446.70905.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T15:41:35Z","timestamp":1650901295000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2791284"}},"subtitle":["A Systematic Review"],"short-title":[],"issued":{"date-parts":[[2022,4,25]]},"references-count":79,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.5964","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,25]]}}}